Measureable residual disease testing for acute myeloid leukemia with single-cell genotyping
Ended Project Grant Awarded Last action
- Award ID
- R44CA247135
- Recipient
-
Mission Bio, Inc. UEI FCSLNELT6DG7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,791,852
Award facts
- Assistance listing
- 93.396 Cancer Biology Research
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$200,471 | |
| Amendment | $992,321 | |
| Amendment | $0 | |
| Original award | $1,000,002 |
Quick answers
Who received award R44CA247135?
R44CA247135 was awarded to Mission Bio, Inc. by National Cancer Institute (National Institutes of Health) on September 12, 2019.
How much is award R44CA247135 worth?
$1,791,852 has been obligated on R44CA247135.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award